Abstract:Fructooligosaccharides (FOS) and inulin are beneficial for human health. However, their benefits differ in individuals who consume prebiotics. Several factors contribute to this variation, including host genetics and differences in the gut microbiota. Bifidobacterium and Bacteroides are strong carbohydrate-utilizing bacteria in the gut, and the level of the Bacteroides / Bifidobacterium (Ba/Bi) ratio in the gut is closely related to the body's ability to utilize prebiotics. However, how to select the type of prebiotics more beneficial for populations with specific Ba/Bi backgrounds and the underlying regulatory mechanisms remain unclear. Here, we explored the dynamics of the gut microbiota and metabolic functions during the in vitro fermentation of FOS and inulin in two different groups: Bacteroides / Bifidobacterium high (H) and Bacteroides / Bifidobacterium low (L). This study revealed that the baseline Ba/Bi ratio had a greater impact on the gut microbiota compared to prebiotic species. Noticeable differences were observed between the two groups after prebiotic intervention, with the H group being more likely to benefit from the prebiotic intervention. Compared to the L group, the H group exhibited significantly higher microbial α-diversity; the co-abundance response group 1 (CARG1) members Ruminococcus gnavus and Blautia involved in the synthesis of propionic and butyric acids increased significantly, the abundance of pathogenic bacteria such as Escherichia Shigella decreased significantly, and the ability to degrade carbohydrates and synthesize fatty acids was greater. Regression modeling showed that the key microbiota could predict the short-chain fatty acid (SCFA) levels, with FOS associated with the ecological roles of CARG2 and CARG7 and inulin associated with CARG4, which provides the basis for the use of prebiotics in nutritional applications and the stratification of populations based on pertinent microbiota profiles to explain the incongruent health effects in human intervention studies.

Inhibitory cortactin nanobodies delineate the role of NTA‐ and SH3‐domain–specific functions during invadopodium formation and cancer cell invasion

Trehalose Metabolism Targeting As a Novel Strategy to Modulate Acid Tolerance of Yeasts and Its Application in Food Industry

Prebiotic Potential of a New Sweetener Based on Galactooligosaccharides and Modified Mogrosides

Vehicular antennas for 800 MHz mobile radio

Galactooligosaccharides: Food Technological Applications, Prebiotic Health Benefits, Microbiome Modulation, And Processing Considerations

Macroglobulin-producing histiocytic lymphoma of hepatic origin.

Galactooligosaccharides: Synthesis, metabolism, bioactivities and food applications

Prebiotic Oligosaccharides Change the Concentrations of Short-Chain Fatty Acids and the Microbial Population of Mouse Bowel.

Growth factors and myointimal hyperplasia in experimental aortic allografts.

Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment.

Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides

Antioxidant Vitamins and Prebiotic FOS and XOS Differentially Shift Microbiota Composition and Function and Improve Intestinal Epithelial Barrier In Vitro

Detection in serum of precipitating Ag/Ab system supposedly with non A non B hepatitis (N.A.N.B.).

DISAPPEARANCE OF ALPHA‐METHYLDOPA INDUCED RED CELL AUTOANTIBODIES DESPITE CONTINUATION OF THE DRUG

In vitro batch fermentation of (un)saturated homogalacturonan oligosaccharides

Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice

Dietary Trehalose as a Bioactive Nutrient

Revealing new leads for the impact of galacto-oligosaccharides on gut commensals and gut health benefits through text mining

Dynamic response of different types of gut microbiota to fructooligosaccharides and inulin

Modulation of the Epithelial-Immune Cell Crosstalk and Related Galectin Secretion by DP3-5 Galacto-Oligosaccharides and β-3′Galactosyllactose

Selective impact of three homogenous polysaccharides with different structural characteristics from Grifola frondosa on human gut microbial composition and the structure-activity relationship